Clinical Trials on Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects in Hong Kong
Totalt 0 resultater
Ingenting funnet
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- Yodogawa Christian Hospital
- Lars Wiuff Andersen
- Home Access Health Corporation
- Durect
- Angus W. Thomson PhD DSc
- SensArs Neuroprosthetics Sarl
- Klaus Kenn
- Ginger Knowledge Transfer and Consultancy Limited
- Luciana Almeida Moreira da Paz Oliveira
- Hospital General de Occidente
- British Heart Foundation Data Science Centre
- Zhe Meng
- Mrs. Thelma Zoegas Foundation
- ChirNet
- Seoul Saint Mary's Hospital
- Hongwen Xu
- School for Midwifery Maastricht
- Dr Gilles DUCHEIX (Attaché)(Clinical Pharmacology center, Inserm 501)
- Giannuzzi Vito
- Molecular Imaging Program, Huntsman Cancer Institute
- Vis full liste
Medisinsk tilstand
- HER2-positiv tilbakevendende eller metastatisk ondartet solid svulst
- Looping
- Mikrovaskulær obstruksjon
- Demografisk data
- TNBC, trippel negativ brystkreft
- Refraktær B-celle akutt lymfatisk leukemi
- Intensiven
- Post-transplantation Liver Allograft Function
- Laryngologiske kirurgiske prosedyrer
- Utsatt posisjonering
- Kroniske, ikke-nevropatiske ryggsmerter
- IQOS-bruk
- Trippel negativ brystkreft
- Forsinket utvikling
- Reduksjon av prosedyresmerte
- Ikke-diabetisk nefropati med hypertensjon
- Medial-lateral brokk
- Tilbakevendende glioblastom, IDH-Wildtype
- Allan-Herndon-Dudley syndrom
- Sacroiliac-ledddysfunksjon
- Vis full liste
Legemiddelintervensjoner
- Hyaluronsyre vaginal gel
- Abraxane
- Ketoconazole 400 mg, sufentanil NanoTab (SUF NT) 15 mcg
- Oversensorisk
- Furosemid
- Aldesleukin
- Cebranopadol 300 µg
- Co-crystal E-58425 (Tramadol/Celecoxib)
- Cisplatin og Gemcitabin
- Prostaglandinanalog
- Propofol postkondisjonering
- RISEDRONATE
- Nivolumab
- TC-5214
- Tocilizumab
- NB-UVB
- Uproleselan
- Aldara – Imiquimod 5 %
- 6 % Bemotrizinol i petrolatum
- Regorafenib, (Stivarga, BAY73-4506)
- Vis full liste
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Canada
- Contract Research Organizations in Germany
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Morocco
- Contract Research Organizations in Oman
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Sweden
- Contract Research Organizations in Uruguay
- CRO list by country